MedPath

Flucytosine

Flucytosine Capsules Rx only

Approved
Approval ID

36e5450b-50fe-438d-b405-bb988667b828

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 16, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flucytosine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-9157
Application NumberNDA017001
Product Classification
M
Marketing Category
C73605
G
Generic Name
Flucytosine
Product Specifications
Route of AdministrationORAL
Effective DateMay 5, 2021
FDA Product Classification

INGREDIENTS (7)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FLUCYTOSINEActive
Quantity: 500 mg in 1 1
Code: D83282DT06
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Flucytosine - FDA Drug Approval Details